Dr. Reddy's Laboratories Limited (RDY)

NYSE: RDY · Real-Time Price · USD

15.38

+0.13 (0.85%)

At close: Jun 26, 2026, 4:00 PM EDT

15.32

-0.06 (-0.39%)

After-hours: Jun 26, 2026, 7:00 PM EDT

Dr. Reddy's Laboratories Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Dr. Reddy's Laboratories stock has a target of 16.16, which predicts an increase of 5.07% from the current stock price of 15.38.

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$16.16	$16.16	$16.16	$16.16
Change	+5.07%	+5.07%	+5.07%	+5.07%

Analyst Ratings

The average analyst rating for Dr. Reddy's Laboratories stock from 5 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Oct '25	Dec '25	Jan '26	Apr '26	May '26	Jun '26
Strong Buy	2	2	2	2	2	2
Buy	0	0	0	0	0	0
Hold	2	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	1	1	1	1	1	1
Total	5	5	5	5	5	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Neha Manpuria Bank of America Securities	Bank of America Securities	Buy Reiterates $16	Buy	Reiterates	$16	+5.09%	Jun 18, 2026
Unknown Analyst Citi No rating	Citi	Sell Maintains n/a	Sell	Maintains	n/a	n/a	Apr 23, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

357.54B

from 335.93B

6.43%

from 335.93B

Revenue Next Year

394.36B

from 357.54B

10.30%

from 357.54B

EPS This Year

52.91

from 55.39

-4.47%

from 55.39

EPS Next Year

64.48

from 52.91

21.86%

from 52.91

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028
Period Ending	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027	Mar 31, 2028
Revenue	214.39B	245.88B	279.16B	325.54B	335.93B	357.54B	394.36B
Revenue Growth	13.00%	14.69%	13.54%	16.61%	3.19%	6.43%	10.30%
EPS	28.34	54.17	66.80	67.78	51.42	52.42	63.91
EPS Growth	36.70%	91.16%	23.32%	1.47%	-24.14%	1.95%	21.90%
Forward PE	-	-	-	-	-	27.67	22.70
No. Analysts	-	-	-	-	-	37	37

Financial currency is INR. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2027	2028
High	390.4B	448.0B
Avg	357.5B	394.4B
Low	334.2B	363.5B

Revenue Growth

Revenue Growth	2027	2028
High	16.2%	25.3%
Avg	6.4%	10.3%
Low	-0.5%	1.7%

EPS Forecast

EPS	2027	2028
High	68.40	80.90
Avg	52.91	64.48
Low	41.20	52.00

EPS Growth

EPS Growth	2027	2028
High	23.5%	52.9%
Avg	-4.5%	21.9%
Low	-25.6%	-1.7%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.